TSC2 c.1717-686G>A

Variant ID: 16-2119771-G-A

NM_000548.3(TSC2):c.1717-686G>A

This variant was identified in 3 publications

View GRCh38 version.




Publications:


The role of TSC2 in breast cancer: a literature review.

Frontiers In Oncology
Zhu, Qiao-Yan QY; He, Zhe-Min ZM; Cao, Wen-Ming WM; Li, Bei B
Publication Date: 2023

Variant appearance in text: rs181088346
PubMed Link: 37251941
Variant Present in the following documents:
  • Main text
  • fonc-13-1188371.pdf
View BVdb publication page



Association of breast cancer risk and the mTOR pathway in women of African ancestry in 'The Root' Consortium.

Carcinogenesis
Wang, Shengfeng S; Huo, Dezheng D; Ogundiran, Temidayo O TO; Ojengbede, Oladosu O; Zheng, Wei W; Nathanson, Katherine L KL; Nemesure, Barbara B; Ambs, Stefan S; Olopade, Olufunmilayo I OI; Zheng, Yonglan Y
Publication Date: 2017-08-01

Variant appearance in text: rs181088346
PubMed Link: 28582508
Variant Present in the following documents:
  • Main text
View BVdb publication page



Genetic variants in the mTOR pathway and breast cancer risk in African American women.

Carcinogenesis
Cheng, Ting-Yuan David TD; Ambrosone, Christine B CB; Hong, Chi-Chen CC; Lunetta, Kathryn L KL; Liu, Song S; Hu, Qiang Q; Yao, Song S; Sucheston-Campbell, Lara L; Bandera, Elisa V EV; Ruiz-Narváez, Edward A EA; Haddad, Stephen S; Troester, Melissa A MA; Haiman, Christopher A CA; Bensen, Jeannette T JT; Olshan, Andrew F AF; Palmer, Julie R JR; Rosenberg, Lynn L
Publication Date: 2016-01

Variant appearance in text: rs181088346
PubMed Link: 26577839
Variant Present in the following documents:
  • Main text
View BVdb publication page